Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector Delivery
Top Cited Papers
- 4 June 2026
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 394 (21) , 2126-2133
Abstract
Recombinant adeno-associated virus (AAV) vectors are predominantly nonintegrating, but rare genomic integration events have been associated with oncogenesis in neonatal murine models. Here we report a case of a neuroepithelial tumor that developed in a 5-year-old boy with severe mucopolysaccharidosis type I (MPSI, Hurler subtype) 4 years after intracisternal magna administration of AAV serotype 9 gene therapy. The patient underwent successful resection of the primary tumor. Postoperatively, he has continued to have advanced cognitive function for his age, a finding that indicates mitigation of MPSI. Molecular analysis of the tumor showed clonal integration of rearranged AAV vector elements into the gene PLAG1 and expression of a chimeric AAV-PLAG1 transcript.Keywords
This publication has 24 references indexed in Scilit:
- PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alterationActa Neuropathologica, 2025
- Current clinical applications of AAV-mediated gene therapyMolecular Therapy, 2025
- Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS IMolecular Therapy - Methods & Clinical Development, 2024
- Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovecMolecular Therapy, 2023
- AAV integration in human hepatocytesMolecular Therapy, 2021
- Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathiesBrain Research, 2020
- Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade GliomasCancer Cell, 2020
- Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector ChimerasMolecular Therapy - Methods & Clinical Development, 2018
- Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation2015
- Real-Time DNA Sequencing from Single Polymerase Molecules2010